🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

As part of the #IASLC50 celebration, we look at the past, present & future. In this episode, host Stephen V Liu, MD focuses on the IASLC today, & some of the ongoing efforts of the IASLC & its members. W/Christian Rolfo, Janet Freeman-Daily & Dr. Emily Stone: bit.ly/LCC50IASLC #LCSM

Still time to register for the STARS Webinar on "Advancing Trustworthy Artificial Intelligence for Cancer Research." Hope you'll join us tomorrow, Thursday, August 29 at 3 pm MDT (Denver time). Once you register, you'll receive the Zoom link via email. iaslc.org/meetings-webin…

Join me at #ILCSC24 Sept 20-21 to learn how #science is helping people live longer! The International Lung Cancer Survivorship Conference (a free virtual event with speakers from around the world) is open to all the #lungcancer community. Register at lungevity.org/ilcsc #lcsm

Looking forward to learning more during next 3 days about informatics used in cancer research. Our patient panel will discuss connecting advocates to researchers. #ITCR2024 #NCIITCR @NCIDataSci

NEW 📣Final FDA Guidance on decentralized #clinicaltrials is out! Covers local labs, imaging, procedures; local healthcare providers; telehealth; informed consent; inv product delivery/accountability; & data mgmt. #MedTwitter #regulatory #DrugDevelopment fda.gov/regulatory-inf…

A treat to hear about novel therapeutic frontiers in fusion positive NSCLC from Dr. Alice Shaw at #CFS24. Profound efficacy with targeted agents for #ALK #ROS1 #RET fusion positive NSCLC - critical to identify these fusions when present. Exciting new drugs coming!

I woke up this morning inspired to write. Here's what popped into my head. #LCSM #lungcancer grayconnections.net/2024/11/16/why…

Trying to surf the wave a little: For those up for a redux on all past ⁦OncLive.com⁩ How This is Building Me podcasts on the people behind cancer, cancer medicine and cancer science - they will be slowly recommented on with links on @drcamidge.bluesky.social

The physician’s duty is not to stave off death or return patients to their old lives, but to take into our arms a patient and family whose lives have disintegrated and work until they can stand back up and face—and make sense of—their own existence. Lucy Kalanithi

A sincere "thank you" to whoever tweaked my X feed to remove ads and people I don't follow.

As we embark on Thanksgiving week I want to take a moment to reflect on this year and my family. Unfortunately I lost my sister to lung cancer in August. It was devastating news when she was diagnosed in 2022 and it's still a shock to believe my vibrant, passionate, loving

When Susan was diagnosed with lung cancer we quickly learned we had many unanswered questions. We launched the @23andme Lung Cancer Community with the intention of getting answers. We brought together over 20 lung cancer advocacy organizations to collectively make a

DEI is not the same as diversity in clinical trials. Diversity in clinical trials aims to test new drugs in a wide variety of people, because response to some medicines can vary by gender, age, ethnicity, and genetics. statnews.com/2025/01/23/fda…

On this #WorldCancerDay, take steps to amp up your lung cancer patient advocacy! Applications are now open for the 2025 IASLC STARS PRA & Scholar Programs. STARS can help you develop and enhance research advocacy skills. iaslc-stars.org

My approach to treatment is: I’m not looking to throw a Hail Mary touchdown — the odds aren’t in my favor. I need to keep getting first downs. First downs keep me in the game, and the longer I'm in the game, the more time research has to catch up! 22 first downs - think about all

A thoughtful perspective on importance of government-supported research infrastructure. It's not perfect, and could use reform. But you can't reform something that disappeared due to lack of funding for labs, support staff, equipment and office space. nytimes.com/2025/02/14/opi…

The entire STAT staff is updating this story about layoffs at HHS. There will be a lot of info. But the short version is this: a lot of the people who would keep drugs safe and effective, to protect patients in trials, and to fight bird flu and future pandemics are gone -- even

Pleased to announce the 2024 ROS1+ Cancer Innovation Award winners! prlog.org/13076799-the-r…

FDA approves taletrectinib for #ROS1 NSCLC based on TRUST I and TRUST II trials showing 1L RR 85-90% with 63-72% of responses lasting ≥12 months and post TKI, RR 52-62%. Taletrectinib has selectivity over TrkB so should have less neurotoxicity. fda.gov/drugs/resource…

📺BREAKING VIDEO Overview: 🚨FDA Approves TALETRECTINIB 🫁NSCLC ROS1+ 🎉 TRUST-I Trial: 90% ORR 📊72% DOR ≥12mo naive!⏲️ 📰 Article With References: oncologytube.com/fda-approves-t… #CancerResearch #LungCancer #ASCO25 Top Biomedical Science OncoAlert gilberto lopes Narjust Florez, MD, FASCO 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏